TABLE 1.
Comparison of Nanogels with other Nanocarriers.
| Parameters | Nanogels | Liposomes | Polymeric nanoparticles | Solid lipid nanoparticles |
|---|---|---|---|---|
| Size | Nanoscale | Variable, typically 50–100 nm | Variable, typically 10–200 nm | Variable, typically 10–500 nm |
| Stability | Good | Moderate | Good | Good |
| Drug Loading | High | Moderate | High | High |
| Release Mechanism | Controlled release | Variable | Variable | Variable |
| Targeting Ability | Can be modified for targeting | Can be modified for targeting | Can be modified for targeting | Can be modified for targeting |
| Penetration | Can penetrate biological barriers | Can penetrate biological barriers | Can penetrate biological barriers | Can penetrate biological barriers |
| Biocompatibility | Generally biocompatible | Generally biocompatible | Generally biocompatible | Generally biocompatible |
| Immunogenicity | Low | Low | Low | Low |
| Advantages | High drug loading capacity, controlled release | Lipid bilayer mimics cell membranes, can encapsulate a | Versatile drug delivery system with tunable properties | Enhanced stability, improved drug |
| ability to target specific sites | wide range of drugs | potential for surface modification | encapsulation | |
| Disadvantages | May require additional steps for synthesis and functionalization | Batch-to-batch variability, limited drug loading ca pacity | Polymeric degradation can lead to loss of stability | May require additional steps for synthesis and functionalization |